Good Steward Wealth Advisors LLC Invests $598,000 in UnitedHealth Group Incorporated (NYSE:UNH)

Good Steward Wealth Advisors LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 1,141 shares of the healthcare conglomerate’s stock, valued at approximately $598,000.

Other large investors also recently modified their holdings of the company. NewSquare Capital LLC bought a new position in UnitedHealth Group during the 4th quarter valued at $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in shares of UnitedHealth Group during the fourth quarter valued at about $26,000. Hurley Capital LLC bought a new stake in UnitedHealth Group in the 4th quarter worth about $28,000. Aster Capital Management DIFC Ltd bought a new stake in UnitedHealth Group during the fourth quarter worth $30,000. Finally, Promus Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $32,000. Institutional investors own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In other news, Director Kristen Gil bought 3,700 shares of the company’s stock in a transaction dated Thursday, May 15th. The stock was bought at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the acquisition, the director now owns 3,818 shares in the company, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Timothy Patrick Flynn purchased 1,533 shares of the stock in a transaction on Wednesday, May 14th. The shares were acquired at an average cost of $320.80 per share, with a total value of $491,786.40. Following the transaction, the director now directly owns 6,033 shares in the company, valued at $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 109,408 shares of company stock worth $31,607,768. Company insiders own 0.28% of the company’s stock.

UnitedHealth Group Trading Down 0.6%

Shares of UnitedHealth Group stock opened at $306.90 on Friday. The company has a 50 day simple moving average of $365.09 and a two-hundred day simple moving average of $465.88. The firm has a market cap of $278.40 billion, a PE ratio of 12.85, a PEG ratio of 1.44 and a beta of 0.44. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the prior year, the company earned $6.91 EPS. Analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.88%. The ex-dividend date of this dividend is Monday, June 16th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s dividend payout ratio (DPR) is presently 37.02%.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research reports. Oppenheimer reduced their target price on shares of UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating for the company in a research report on Wednesday, May 14th. Piper Sandler decreased their target price on UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating for the company in a research report on Tuesday, June 3rd. TD Securities reiterated a “hold” rating and set a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Robert W. Baird cut UnitedHealth Group from an “outperform” rating to a “neutral” rating and set a $312.00 price objective on the stock. in a research note on Wednesday, June 11th. Finally, Hsbc Global Res lowered UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a report on Wednesday, May 21st. One analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $426.52.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.